Skip to main content

Arcturus Therapeutics Holdings Inc.

ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001768224

No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.

13F holders, Q2 2022

Institutional positions in Arcturus Therapeutics Holdings Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
+2 vs. Q1 2022
Shares held
22.2M
+748.9K (+3.5%) vs. Q1 2022
Total value
$353.6M
−$223.3M (−38.7%) vs. Q1 2022
New holders
16
49 more added
Sold out
14
32 more reduced

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ARCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 128 institutions
Q1 2021: 162 institutionsQ2 2021: 139 institutionsQ3 2021: 157 institutionsQ4 2021: 139 institutionsQ1 2022: 129 institutionsQ2 2022: 128 institutionsQ3 2022: 117 institutionsQ4 2022: 113 institutionsQ1 2023: 124 institutionsQ2 2023: 144 institutionsQ3 2023: 147 institutionsQ4 2023: 166 institutionsQ1 2024: 179 institutionsQ2 2024: 171 institutionsQ3 2024: 164 institutionsQ4 2024: 149 institutionsQ1 2025: 147 institutionsQ2 2025: 145 institutionsQ3 2025: 137 institutionsQ4 2025: 121 institutionsQ1 2026: 124 institutionsQ2 2026: 135 institutions
Value heldQ2 2022: $353.6M
Q1 2021: $776.0MQ2 2021: $694.0MQ3 2021: $909.0MQ4 2021: $736.2MQ1 2022: $578.1MQ2 2022: $353.6MQ3 2022: $328.1MQ4 2022: $383.9MQ1 2023: $557.9MQ2 2023: $677.6MQ3 2023: $643.1MQ4 2023: $801.6MQ1 2024: $918.7MQ2 2024: $640.0MQ3 2024: $609.3MQ4 2024: $452.5MQ1 2025: $282.9MQ2 2025: $336.3MQ3 2025: $476.8MQ4 2025: $145.1MQ1 2026: $187.3MQ2 2026: $167.9M
Institutions holding ARCT and their total value by quarter
QuarterHoldersValue
Q2 2026135$167.9M
Q1 2026124$187.3M
Q4 2025121$145.1M
Q3 2025137$476.8M
Q2 2025145$336.3M
Q1 2025147$282.9M
Q4 2024149$452.5M
Q3 2024164$609.3M
Q2 2024171$640.0M
Q1 2024179$918.7M
Q4 2023166$801.6M
Q3 2023147$643.1M
Q2 2023144$677.6M
Q1 2023124$557.9M
Q4 2022113$383.9M
Q3 2022117$328.1M
Q2 2022128$353.6M
Q1 2022129$578.1M
Q4 2021139$736.2M
Q3 2021157$909.0M
Q2 2021139$694.0M
Q1 2021162$776.0M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Arcturus Therapeutics Holdings Inc.; share changes are against Q1 2022.

Institutions holding ARCT in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vontobel Holding Ltd.76,810$1.21M0.01%+38,307+99.5%Added
Royce & Associates LP79,836$1.26M0.01%00.0%Unchanged
Nuveen Asset Management, LLC108,606$1.71M0.00%+17,148+18.7%Added
Bank Julius Baer & Co. Ltd, Zurich124,838$1.97M0.01%−92,425−42.5%Reduced
Citigroup Inc126,874$2.00M0.00%+80,559+173.9%Added
Susquehanna International Group, LLP140,702$2.21M0.00%+10,200+7.8%Added
Dimensional Fund Advisors LP149,392$2.35M0.00%−68,180−31.3%Reduced
Charles Schwab Investment Management Inc156,258$2.46M0.00%+1,707+1.1%Added
Integral Health Asset Management, LLC156,553$2.46M0.51%+31,553+25.2%Added
Wells Fargo & Company176,149$2.77M0.00%+19,530+12.5%Added
Rafferty Asset Management, LLC200,186$3.15M0.03%−102,004−33.8%Reduced
Millennium Management LLC204,596$3.22M0.00%+204,596New
Northern Trust Corp208,896$3.29M0.00%+15,187+7.8%Added
ACT Capital Management, LLC226,600$3.57M4.99%−26,700−10.5%Reduced
Schonfeld Strategic Advisors LLC267,597$4.21M0.04%+191,501+251.7%Added
Morgan Stanley312,211$4.91M0.00%+32,241+11.5%Added
JPMorgan Chase & Co325,060$5.12M0.00%−750.0%Reduced
Goldman Sachs Group Inc370,337$5.83M0.00%+88,347+31.3%Added
Geode Capital Management, LLC392,537$6.18M0.00%+21,554+5.8%Added
Point72 Asset Management, L.P.913,323$14.4M0.07%+488,123+114.8%Added
FMR LLC920,757$14.5M0.00%−390.0%Reduced
Nikko Asset Management Americas, Inc.1,436,194$18.0M0.22%+34,116+2.4%Added
Vanguard Group Inc1,193,656$18.8M0.00%+40,143+3.5%Added
Sumitomo Mitsui Trust Holdings, Inc.1,436,194$22.6M0.02%+34,116+2.4%Added
BlackRock Inc.1,904,302$30.0M0.00%+208,663+12.3%Added
State Street Corp2,806,918$44.2M0.00%−411,039−12.8%Reduced
ARK Investment Management LLCSuperinvestorARK Invest2,303,751$45.8M0.27%−80,089−3.4%Reduced
Federated Hermes, Inc.3,561,097$56.1M0.15%−200,803−5.3%Reduced
Granahan Investment Management Inc0$00.00%−64,851−100.0%Sold out
Simplex Trading, LLC0$00.00%−19,710−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−17,692−100.0%Sold out
LPL Financial LLC0$00.00%−13,041−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−8,352−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−8,300−100.0%Sold out
Voya Investment Management LLC0$00.00%−8,282−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−838−100.0%Sold out
Old Second National Bank of Aurora0$00.00%−200−100.0%Sold out
Prospera Financial Services Inc0$00.00%−100−100.0%Sold out
Toth Financial Advisory Corp0$00.00%−30−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−21−100.0%Sold out
Glassman Wealth Services0$00.00%−1−100.0%Sold out
Concord Wealth Partners0$00.00%−3−100.0%Sold out
Susquehanna Fundamental Investments, LLC––––Not filed
IndexIQ Advisors LLC––––Not filed
Amalgamated Financial Corp.––––Not filed